Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity
Journal of Neurology, Neurosurgery and Psychiatry · Published 2026-01-20 · DOI 10.1136/jnnp-2025-337944
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1136/jnnp-2025-337944
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Related articles
- Disease Course After Anti‐ CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study · Annals of Clinical and Translational Neurology · 2026 · Cites or is cited by this article
- Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal) · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- Steroids or immunoglobulin for CIDP first-line treatment: why not both? · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- Diagnostic performance of machine learning models versus established risk stratification for intracranial aneurysm rupture: a systematic review and bivariate meta-analysis · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- Evaluation of metformin for epilepsy prevention or seizure control in people without evidence of diabetes: retrospective cohort study · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- Acquired vitamin B6 deficiency in POEMS: a marker of disease activity and cause of neuropathy? · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- DNA methylation profiling in central nervous system tumours · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- Migration status, country of origin and long-term outcomes in multiple sclerosis: a Swedish nationwide study · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal
- Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study · Journal of Neurology, Neurosurgery and Psychiatry · 2026 · Same journal